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October 20111228 Abstractsdirect and indirect hospital costs of the initial and subsequent reinterven-
tions was applied to a prospectively collected vascular database. Analysis
was done via Student t test and log-ranked Kaplan-Meier analysis.
Results: The mean length in the ER group was 18.5 cm. A prosthetic
conduit was used in 51% of SR group. Patency at 1 year was similar in both groups
and superior for SR thereafter. The rate of all reinterventions was 28 of 85 (33%) in
ER and 40 of 98 (41%) in SR. The average hospital costs for the SR group were
significantly greater than costs for the ER group ($18,506 $,877 vs $11,740
$709, P  .005); however, this difference was not significant when comparing
amortized costs per day of patency at 1 year ($82 $21 vs $136 103), 2 years
($55$28 vs $152134), 3 years ($56 $44 vs $16 3), or 4 years ($8$1
vs $10 $2) in patients with claudication or chronic limb ischemia.
Conclusions: The amortized cost/day model is valuable for evaluating
resource utilization, enabling us to examine the cost efficacy of the proce-
dure, patency, and reinterventions. Our findings indicate that although
initially endovascular therapy for femoropopliteal occlusive disease is associ-
ated with significant savings, long term the amortized cost per day is
comparable in selected patients undergoing ER or SR.
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Introduction and objectives:Major amputation is associated with signif-
icant short-term health care resource utilization (RU), high mortality, and socio-
economicdisparities.Patient-specific and socioeconomic-relatedpredictorsof long-
term RU and survival after amputation have not been studied in detail.
Methods: Retrospective analysis identified 364 patients who underwent
primary major amputation for CLI from January 1995 to December 2000 at
two tertiary centers with outcomes through December 2010. Age, sex, race,
income, insurance, marital status, congestive heart failure (CHF), diabetes
mellitus (DM), complicated DM, renal failure, amputation level, additional
procedures, cumulative length of stay (cLOS), and mortality were analyzed.
Multivariate Poisson regression for additional procedures and cLOS, and Cox
proportional hazard modeling for all-cause mortality were undertaken.
Results:During amean follow-up of 3.25 years, patients hadmean cLOSof
37.4 days (median, 22), 5.54 readmissions (median, 4), 0.39 additional amputa-
tion-related procedures (median, 0), and 0.25 cardiovascular procedures (median,
0). Of readmissions 30 days, 52% were amputation-related. Mortality during
follow-up was 86.9%, with 37 patients (10.2%) dying 30 days. Among
those who survived 30 days, complicated DM, renal failure, and below
knee amputation were associated with additional amputation procedures.
CHF and renal failure were associated with a greater number of cardiovas-
cular procedures. Younger age, public insurance, being uninsured, CHF,
and renal failure were associated with increased cLOS. Older age, CHF,
renal failure, and undergoing above knee amputation decreased survival.
Race and income were not significantly related to the outcomes (Table).
Table. Outcomes after amputation
Outcome Incidence RR 95% CI P
Additional amputations
Variable
Complicated DM 1.897 1.085-3.317 .025
Renal failure 2.471 1.381-4.422 .002
Below knee amputation 2.425 1.103-5.331 .028
Outcome
Cardiovascular procedures
Variable
CHF 1.829 1.074-3.114 .026
Renal failure 3.669 2.309, 5.830 .0001
Cumulative LOS
Variable
Age 0.984 0.973-0.994 .002
Public insurance 1.627 1.166-2.269 .004
Uninsured 2.056 1.093-3.868 .025
CHF 1.605 1.123-2.293 .010
Renal failure 2.117 1.545, 2.900 .0001
Death
Variable Hazard ratio
Age 1.035 1.022-1.048 .0001
CHF 2.260 1.682-3.036 .0001
Renal failure 2.596 1.904-3.539 .0001
Above knee amputation 1.365 1.045-1.784 .023CHF, Congestive heart failure; CI, confidence interval; DM, diabetes mel-
litus; LOS, length of stay; RR, rate ratio.
a
mConclusions: Mortality and RU are high for amputees. Increased RU
ersists beyond the perioperative period. Results were similar across socio-
conomic groups, suggesting socioeconomic status does not predict RU
nce limb salvage is no longer attainable. Socioeconomic disparities may be
ore modifiable during earlier stages of CLI.
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Introduction and objectives: Femoropopliteal artery occlusive le-
ion analysis was used to develop a comprehensive lesion severity score (LSS)
hat can predict patency after endovascular intervention (EVI).
able I. Independent factors predicting loss of patency
nd predictive factor score
Variablea Score
Cox
coefficient HR (95% CI) P
Diabetes 1 0.28 1.33 (1.05-1.68) .0159
Congestive heart
failure
1 0.29 1.35 (1.04-1.75) .0268
Lesion length
100 mm
2 0.46 1.59 (1.31-1.94) .001
Stenosis 80%-99% 2 0.35 1.42 (1.13-1.80) .0033
Chronic total
occlusion
3 0.56 1.76 (1.34-2.29) .001
I, Confidence interval; HR, hazard ratio.
Some factors not found not statistically significant were age, sex, weight,
ody mass index, renal disease, coronary artery disease, degree of calcifica-
ion, lesion length categories 100 mm, lesion stenosis 80%, tibial runoff
tatus.
able II. Patency based on lesion severity score (LSS)
LSS
Patency, % (95% CI)
6 months 12 months 24 months 36 months
0-1 89 (84-92) 81 (75-85) 71 (64-77) 69 (61-75)
2-3 82 (77-85) 68 (63-73) 57 (51-62) 51 (45-57)
4-5 76 (70-80) 55 (49-61) 41 (34-47) 32 (25-39)
6-7 71 (63-77) 44 (36-53) 26 (18-35) 15 (9-24)
Methods: A prospective database of all EVIs for femoropopliteal
esions from 2005 to 2009 was evaluated. Independent risk factors and
atency rates were analyzed by life-table analysis and Cox proportional
azards regression.
Results: Of 1776 lesions in our prospective database, 1329 were
iscrete femoropopliteal lesions in 675 patients (56.4% men; age, 72.4
ears). Analysis showed 17.5% of femoropopliteal lesions had a concomi-
antly treated tibial lesion. Among the 44 variables that were examined were
atient demographics and lesion characteristics, including degree of calcifi-
ation, length, and degree of stenosis of the lesion, chronic total occlusions,
nd the runoff status. Factors that predicted patency of lesions differed by
he location of the lesion. Only factors that independently predicted patency
pecifically for lesions of the femoral and popliteal artery were included in the
SS. The effect of each independent variable on patency was evaluated by
ox proportional hazards regression and assigned a score for the LSS (Table
). Patency after EVIs using the calculated LSS was assessed, and a strong
orrelation was revealed between the increasing LSS and significantly wors-
ning patency (Table II).
Conclusions: This novel LSS comprehensively combines patient co-
orbidities and lesion-specific factors in predicting long-term patency after
VI for the femoropopliteal vessels. Once further validated, this LSS will
llow for comprehensive comparison and classification of lesions and treat-
ent options even among multiple studies.
